Skip to Content
Biotechnology and health

Scientists just showed how to drive malaria mosquitoes to extinction

September 24, 2018

A team in the UK has caused a buzzing cage full of mosquitoes to “crash” and die out after releasing sex-distorting DNA into their gene pool. The researchers say they eventually hope to use the technology, called a gene drive, to make malaria-carrying mosquitoes extinct in Africa.

The problem: The malaria parasite, spread by mosquitoes, infected some 216 million people worldwide in 2016 and killed 445,000 of them, according to Reuters. There’s no vaccine.

Gene gadget: A gene drive is a man-made genetic construct that spreads faster than usual as animals reproduce. The technology, in effect, provides a way to spread genetic alterations among wild organisms.

Last mosquito standing: A team at Imperial College London say they used a gene drive to spread broken copies of a gene that controls which sex a mosquito becomes. The genes turns female mosquitoes into hermaphrodites that can’t bite or lay eggs. The result was published in Nature Biotechnology today.

The experiments were carried out in cages. After eight generations, no normal females were left to have offspring, and the mosquitoes died out, they report. The project at Imperial College, called Target Malaria, is funded by the Bill & Melinda Gates Foundation, which has put more than $70 million into it.

Into Africa: Lead biologist Andrea Crisanti said it would be five to 10 years before gene-drive mosquitoes could be tested in the wild. “I regard a mosquito that transmits malaria as a pathogen—and as a pathogen we have the right to eliminate it,” Cristanti told NPR. “We have eliminated viruses like smallpox. We are trying to eliminate polio. I don’t see a big difference.”

Risks? Genetic poisoning via reproduction is more precise than insecticides, as it affects only one species. For background on Target Malaria, see our 2016 feature “The extinction invention.”

Deep Dive

Biotechnology and health

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

A biotech company says it put dopamine-making cells into people’s brains

The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.

Tiny faux organs could crack the mystery of menstruation

Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.

After 25 years of hype, embryonic stem cells are still waiting for their moment

Research roadblocks and political debates have delayed progress—but scientists are inching closer to delivering a cure. 

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.